SELLAS Life Sciences Group, Inc. Common Stock (SLS) Stock Price, Quote & AI Analysis
Live SLS stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for SELLAS Life Sciences Group, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for SELLAS Life Sciences Group, Inc. Common Stock (SLS), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
SELLAS Life Sciences Group, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
SELLAS Life Sciences Group, Inc. Common Stock Overview
Company information
Company Overview
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
SELLAS Life Sciences Group, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...